טוען...
TIMs, TAMs, and PS- antibody targeting: implications for cancer immunotherapy
Immunotherapy for cancer is making impressive strides at improving survival of a subset of cancer patients. To increase the breadth of patients that benefit from immunotherapy, new strategies that combat the immunosuppressive microenvironment of tumors are needed. Phosphatidylserine (PS) signaling i...
שמור ב:
| הוצא לאור ב: | Cell Commun Signal |
|---|---|
| Main Authors: | , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
BioMed Central
2020
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7036251/ https://ncbi.nlm.nih.gov/pubmed/32087708 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12964-020-0521-5 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|